Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Biosensors International Stories

2013-02-19 08:32:33

SOMERSET, N.J., Feb. 19, 2013 /PRNewswire/ -- Terumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey. The complaint alleges that R Band(TM) Radial Hemostasis Device distributed by Vascular Solutions and manufactured by Lepu Medical Technology infringes on a patent and trademark, which Terumo Medical Corporation holds the U.S....

2013-02-07 12:27:23

SINGAPORE, Feb. 7, 2013 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, has announced a collaboration with Terumo Corporation to promote the Nobori(TM) drug-eluting stent (DES) system at specific specialist cardiology centers in Japan. Nobori incorporates two elements of Biosensors-developed technology: Biolimus A9(TM)...

2013-02-07 12:27:06

SINGAPORE, Feb. 7, 2013 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its third fiscal quarter ("Q3 FY13") and nine months ended 31 December 2012 ("FY13 nine-month period"). Financial Performance and Recent Highlights: In January, Biosensors received CE Mark approval for its polymer-free...

2013-01-28 20:21:55

SINGAPORE, Jan. 28, 2013 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced CE Mark approval for its polymer-free drug-coated stent (DCS), BioFreedom(TM). BioFreedom represents the latest development in Biosensors' stent technology, featuring a micro-structured abluminal surface which permits the controlled release of Biolimus...

2012-12-03 12:27:28

Global Trial Led by Dr. Dean Kereiakes of Lindner Research Center CINCINNATI, Dec. 3, 2012 /PRNewswire-USNewswire/ -- Clinical scientists at The Christ Hospital's Lindner Research Center are leading a worldwide study evaluating new breakthrough coronary stent technology that may make stenting easier and safer. The first procedures to implant the novel SYNERGYâ"¢ stent were performed at The Christ Hospital by Drs. Thomas Broderick and Joseph Choo, interventional...

2012-11-07 08:28:52

SINGAPORE, Nov. 7, 2012 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG:SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for the second quarter of fiscal year 2013 (Q2 FY13) and the fiscal six months ended 30 September 2012 (H1 FY13). Q2 FY13 and Recent Highlights: Total revenue of US$79.8 million, representing 28% year-on-year growth Interventional...

2012-11-06 08:27:45

DURHAM, N.C., Nov. 6, 2012 /PRNewswire/ -- Micell Technologies, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a patent covering the company's surface and polymer modification technology. This intellectual property protection is related to Micell's investigational MiStent(®) Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(TM)), as well as potential additional biomedical products. The patent rights are assigned to and...

2012-10-30 11:25:44

HELMOND, The Netherlands, October 30, 2012 /PRNewswire/ -- Innovator in the treatment of vascular diseases launches non compliant DEB worldwide Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announced receiving the CE mark for Protege NC, a non compliant drug eluting balloon. The new device will be launched worldwide. It follows the introduction of Blue Medical's CE marked Drug Eluting Balloon Protege and CoCr...

2012-10-16 11:25:29

HONG KONG, Oct. 16, 2012 /PRNewswire/ -- OrbusNeich today announced that multiple presentations of clinical data for the COMBO Dual Therapy Stent will take place next week at TCT 2012 in Miami Beach. The scientific sessions will feature cumulative results from the REMEDEE study (Randomized Evaluation of an abluMinal sirolimus coatED bio-Engineered stEnt), a randomized trial of the COMBO Dual Therapy Stent versus a drug eluting stent, and data from the REMEDEE OCT and EGO COMBO studies to...

2012-10-01 02:29:57

SINGAPORE, Oct. 1, 2012 /PRNewswire-FirstCall/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20) and Terumo Corporation ("Terumo") announced today an extension of their existing licensing agreements, under which Terumo may continue to incorporate BioMatrix(TM) technology in the production, marketing and selling of Terumo's drug-eluting stent (DES) systems in markets worldwide, outside of the United States. Terumo is one of...